FDA Inspection
Lilly del Caribe, Inc.Lilly del Caribe, Inc. – FDA Inspection, Jul 31, 2009
Record Details
This FDA Inspection record concerns Lilly del Caribe, Inc., with an inspection on July 31, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Lilly del Caribe, Inc.
- Inspection Date
- July 31, 2009
- Product Type
- Drugs
View Company Profile
ID · 0fa8b6f9-1bcb-444c-8eed-141674da7034
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 600975
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lilly del Caribe, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 12, 2026 | Not classified | San Juan District Office | |
| February 17, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 1, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lilly del Caribe, Inc.
- FDA Inspection 1321482 - 2026-05-12
- FDA Inspection 1198613 - 2023-02-17
- FDA Inspection 1069980 - 2018-09-27
- FDA Inspection 974723 - 2016-06-01
- FDA Inspection 868382 - 2014-02-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.